Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Sienna Biopharmaceuticals, Inc. (SNNA) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/03/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
08/03/2018 3 Hindman James M. (Director) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
04/18/2018 3 Smither John W (CFO) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
07/26/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
07/26/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
07/26/2017 3 Stroehmann Diane (See Remarks) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
07/26/2017 3 PETERSON RICHARD D (CFO) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
07/26/2017 3 MORE ROBERT J (Director) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
07/26/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
07/26/2017 3 Lizzul Paul F. (Chief Medical Officer) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
07/26/2017 3 Leonard Keith R (Director) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
07/26/2017 3 Harris Todd (Head of Corporate Development) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.
07/26/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
07/26/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
07/26/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
07/26/2017 3 Andrews Timothy K. (General Counsel & Secretary) has filed a Form 3 on Sienna Biopharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy